4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

This publication has 22 references indexed in Scilit:

• Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic Shock
  Clinical Infectious Diseases, 1999
• The Relationship between Plasminogen Activator Inhibitor-1 and Proinflammatory and Counterinflammatory Mediators in Children with Meningococcal Septic Shock
  The Journal of Infectious Diseases, 1996
• The role of hemolymph coagulation in innate immunity
  Current Opinion in Immunology, 1996
• The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans
  The Pediatric Infectious Disease Journal, 1994
• Deficiency of prostacyclin production in meningococcal shock.
  Archives of Disease in Childhood, 1991
• Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects
  New England Journal of Medicine, 1989
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
  The Journal of Experimental Medicine, 1989
• Elastase-α1-proteinase inhibitor: An early indicator of septicemia and bacterial meningitis in children
  The Journal of Pediatrics, 1987
• Purpura Fulminans in Meningococcemia: Association with Acquired Deficiencies of Proteins C and S
  New England Journal of Medicine, 1987
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
  Journal of Clinical Investigation, 1987